THE RELATIVE POTENCIES OF ANTI‐INFLUENZA COMPOUNDS
Identifieur interne : 002A85 ( Main/Exploration ); précédent : 002A84; suivant : 002A86THE RELATIVE POTENCIES OF ANTI‐INFLUENZA COMPOUNDS
Auteurs : Margaret Tisdale [Royaume-Uni] ; D. J. Bauer [Royaume-Uni]Source :
- Annals of the New York Academy of Sciences [ 0077-8923 ] ; 1977-05.
Descripteurs français
- KwdFr :
- Adamantane (analogues et dérivés), Adamantane (pharmacologie), Amantadine (pharmacologie), Amines (pharmacologie), Animaux, Antiviraux (pharmacologie), Antiviraux (usage thérapeutique), Cellules cultivées, Cycloparaffines (pharmacologie), Infections à Orthomyxoviridae (traitement médicamenteux), Ribavirine (pharmacologie), Souris, Tests de sensibilité microbienne, Virus de la grippe A ().
- MESH :
- analogues et dérivés : Adamantane.
- pharmacologie : Adamantane, Amantadine, Amines, Antiviraux, Cycloparaffines, Ribavirine.
- traitement médicamenteux : Infections à Orthomyxoviridae.
- usage thérapeutique : Antiviraux.
- Animaux, Cellules cultivées, Souris, Tests de sensibilité microbienne, Virus de la grippe A.
English descriptors
- KwdEn :
- Adamantane (analogs & derivatives), Adamantane (pharmacology), Amantadine (pharmacology), Amines (pharmacology), Animals, Antiviral Agents (pharmacology), Antiviral Agents (therapeutic use), Cells, Cultured, Cycloparaffins (pharmacology), Influenza A virus (drug effects), Mice, Microbial Sensitivity Tests, Orthomyxoviridae Infections (drug therapy), Ribavirin (pharmacology).
- MESH :
- chemical , analogs & derivatives : Adamantane.
- chemical , pharmacology : Adamantane, Amantadine, Amines, Antiviral Agents, Cycloparaffins, Ribavirin.
- chemical , therapeutic use : Antiviral Agents.
- drug effects : Influenza A virus.
- drug therapy : Orthomyxoviridae Infections.
- Animals, Cells, Cultured, Mice, Microbial Sensitivity Tests.
Url:
DOI: 10.1111/j.1749-6632.1977.tb21958.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000438
- to stream Istex, to step Curation: 000438
- to stream Istex, to step Checkpoint: 001663
- to stream PubMed, to step Corpus: 000634
- to stream PubMed, to step Curation: 000634
- to stream PubMed, to step Checkpoint: 000543
- to stream Ncbi, to step Merge: 000D34
- to stream Ncbi, to step Curation: 000D34
- to stream Ncbi, to step Checkpoint: 000D34
- to stream Main, to step Merge: 002C46
- to stream Main, to step Curation: 002A85
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">THE RELATIVE POTENCIES OF ANTI‐INFLUENZA COMPOUNDS</title>
<author><name sortKey="Tisdale, Margaret" sort="Tisdale, Margaret" uniqKey="Tisdale M" first="Margaret" last="Tisdale">Margaret Tisdale</name>
</author>
<author><name sortKey="Bauer, D J" sort="Bauer, D J" uniqKey="Bauer D" first="D. J." last="Bauer">D. J. Bauer</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:AC60933597E91FBED3562DB74366744F1F57A6C2</idno>
<date when="1977" year="1977">1977</date>
<idno type="doi">10.1111/j.1749-6632.1977.tb21958.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-4HDHZ5SQ-R/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000438</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000438</idno>
<idno type="wicri:Area/Istex/Curation">000438</idno>
<idno type="wicri:Area/Istex/Checkpoint">001663</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001663</idno>
<idno type="wicri:doubleKey">0077-8923:1977:Tisdale M:the:relative:potencies</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:280137</idno>
<idno type="wicri:Area/PubMed/Corpus">000634</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000634</idno>
<idno type="wicri:Area/PubMed/Curation">000634</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000634</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000543</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000543</idno>
<idno type="wicri:Area/Ncbi/Merge">000D34</idno>
<idno type="wicri:Area/Ncbi/Curation">000D34</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000D34</idno>
<idno type="wicri:doubleKey">0077-8923:1977:Tisdale M:the:relative:potencies</idno>
<idno type="wicri:Area/Main/Merge">002C46</idno>
<idno type="wicri:Area/Main/Curation">002A85</idno>
<idno type="wicri:Area/Main/Exploration">002A85</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">THE RELATIVE POTENCIES OF ANTI‐INFLUENZA COMPOUNDS</title>
<author><name sortKey="Tisdale, Margaret" sort="Tisdale, Margaret" uniqKey="Tisdale M" first="Margaret" last="Tisdale">Margaret Tisdale</name>
<affiliation wicri:level="2"><country>Royaume-Uni</country>
<placeName><region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>Wellcome Research Laboratories Beckenham</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Bauer, D J" sort="Bauer, D J" uniqKey="Bauer D" first="D. J." last="Bauer">D. J. Bauer</name>
<affiliation wicri:level="2"><country>Royaume-Uni</country>
<placeName><region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>Wellcome Research Laboratories Beckenham</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Annals of the New York Academy of Sciences</title>
<title level="j" type="alt">ANNALS OF NEW YORK ACADEMY SCIENCES</title>
<idno type="ISSN">0077-8923</idno>
<idno type="eISSN">1749-6632</idno>
<imprint><biblScope unit="vol">284</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="254">254</biblScope>
<biblScope unit="page" to="263">263</biblScope>
<biblScope unit="page-count">10</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="1977-05">1977-05</date>
</imprint>
<idno type="ISSN">0077-8923</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0077-8923</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adamantane (analogs & derivatives)</term>
<term>Adamantane (pharmacology)</term>
<term>Amantadine (pharmacology)</term>
<term>Amines (pharmacology)</term>
<term>Animals</term>
<term>Antiviral Agents (pharmacology)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Cells, Cultured</term>
<term>Cycloparaffins (pharmacology)</term>
<term>Influenza A virus (drug effects)</term>
<term>Mice</term>
<term>Microbial Sensitivity Tests</term>
<term>Orthomyxoviridae Infections (drug therapy)</term>
<term>Ribavirin (pharmacology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adamantane (analogues et dérivés)</term>
<term>Adamantane (pharmacologie)</term>
<term>Amantadine (pharmacologie)</term>
<term>Amines (pharmacologie)</term>
<term>Animaux</term>
<term>Antiviraux (pharmacologie)</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Cellules cultivées</term>
<term>Cycloparaffines (pharmacologie)</term>
<term>Infections à Orthomyxoviridae (traitement médicamenteux)</term>
<term>Ribavirine (pharmacologie)</term>
<term>Souris</term>
<term>Tests de sensibilité microbienne</term>
<term>Virus de la grippe A ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Adamantane</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Adamantane</term>
<term>Amantadine</term>
<term>Amines</term>
<term>Antiviral Agents</term>
<term>Cycloparaffins</term>
<term>Ribavirin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Adamantane</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Influenza A virus</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Orthomyxoviridae Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Adamantane</term>
<term>Amantadine</term>
<term>Amines</term>
<term>Antiviraux</term>
<term>Cycloparaffines</term>
<term>Ribavirine</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à Orthomyxoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Cells, Cultured</term>
<term>Mice</term>
<term>Microbial Sensitivity Tests</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Cellules cultivées</term>
<term>Souris</term>
<term>Tests de sensibilité microbienne</term>
<term>Virus de la grippe A</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
</region>
</list>
<tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Tisdale, Margaret" sort="Tisdale, Margaret" uniqKey="Tisdale M" first="Margaret" last="Tisdale">Margaret Tisdale</name>
</region>
<name sortKey="Bauer, D J" sort="Bauer, D J" uniqKey="Bauer D" first="D. J." last="Bauer">D. J. Bauer</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002A85 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002A85 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= H2N2V1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:AC60933597E91FBED3562DB74366744F1F57A6C2 |texte= THE RELATIVE POTENCIES OF ANTI‐INFLUENZA COMPOUNDS }}
![]() | This area was generated with Dilib version V0.6.33. | ![]() |